Apollo Hospitals is well placed and executed very well over the last few years, says UBS India's Gautam Chhaochharia. "This has shown in secular earnings growth in the past and has given investors a lot of confidence," he adds.
Gautam Chhaochharia of UBS India says the markets will start factoring Petronet LNG's growth and expansion gradually and that will drive the stock up from current levels.
The the outlook on the replacement market still remains very good despite a tough macro environment we are bullish on Exide Industries. The stock has valuations that are supportive and there is potential for earnings upgrades
The pharma story is similar both on the generic front as well as on local businesss so we like IPCA laboratories ays Gautam Chhaochharia, UBS India
Gautam Chhaochharia of UBS India says he likes Raymond. He sees almost 40 percent plus upside from current levels.
Gautam Chhaochharia of UBS India says he continued to be overweight on banking space.
UBS India's Gautam Chhaochharia says from a strategy point of view IT services remains the best way to play the Indian rupee depreciation theme rather than pharmaceuticals.
Gautam Chhaochharia of UBS India feels valuation of Jaiprakash Associates is very attractive as the company has a good portfolio of ready assets.
Gautam Chhaochharia of UBS India advised selling Tata Motors as the risk-reward is clearly unfavourable.
Gautam Chhaochharia of UBS India feels Cairn India looks very attractive as there is some visibility in terms of production ramp up ahead.
Gautam Chhaochharia of UBS India expects Indian consumption theme to under perform this year.